Choi Joon Ho, Park Yong-Jin, Lee Hyunjong, Kwon Hye Ryeong, Oh Jinkyoung, Lim Chae Hong, Han Eun Ji, Choi Joon Young
Department of Nuclear Medicine, Soonchunhyang University Hospital Bucheon, Bucheon, Republic of Korea.
Department of Nuclear Medicine, Ajou University Medical Center, Ajou University School of Medicine, Suwon, Republic of Korea.
Nucl Med Mol Imaging. 2025 Feb;59(1):27-40. doi: 10.1007/s13139-024-00894-x. Epub 2024 Dec 5.
This guideline outlines the use of F-fluoro-2-deoxyglucose positron emission tomography / computed tomography for the diagnosis and management of infectious and inflammatory diseases. It provides detailed recommendations for healthcare providers on patient preparation, imaging procedures, and the interpretation of results. Adapted from international standards and tailored to local clinical practices, the guideline emphasizes safety, quality control, and effective use of the technology in various conditions, including spinal infections, diabetic foot, osteomyelitis, vasculitis, and cardiac inflammation. The aim is to assist nuclear medicine professionals in delivering accurate diagnoses and improving patient outcomes while allowing flexibility to adapt to individual patient needs, technological advancements, and evolving medical knowledge. This document is a comprehensive resource for enhancing the quality and safety of F-fluoro-2-deoxyglucose positron emission tomography / computed tomography for the evaluation of infectious and inflammatory diseases.
The Korean Society of Nuclear Medicine (KSNM) was established in 1961 to promote the clinical and technological advancement of nuclear medicine in South Korea, with members that include nuclear medicine physicians and associated scientists. The KSNM regularly formulates and revises procedural guidelines for nuclear medicine examinations to enhance the field and improve the quality of patient care. These guidelines are designed to support healthcare professionals in providing appropriate medical care to patients. However, they are not immutable rules or mandatory requirements for conducting examinations.Therefore, KSNM states that these guidelines should not be used in legal actions challenging a healthcare professional's medical decisions. The ultimate judgment regarding specific procedures or appropriate measures should be made by nuclear medicine physicians, considering the unique circumstances of each case. Deviation from these guidelines does not imply substandard medical practice. Rather, reasonable judgments differing from the guidelines can be made based on the patient's condition, available resources, and advancements in knowledge or technology. Due to the diversity and complexity of patients, it is often challenging to predict the most appropriate diagnostic and accurate therapeutic responses. Thus, adherence to these guidelines does not always guarantee an exact diagnosis or successful outcomes.The purpose of this guideline is to assist healthcare providers in making reasonable decisions and conducting effective and safe examinations based on current medical knowledge, available resources, and patient needs when performing 18F-fluoro-2-deoxyglucose (18F-FDG) positron emission tomography (PET)/computed tomography (CT) examinations for infectious/inflammatory diseases.
本指南概述了氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描（F-氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描）在感染性和炎症性疾病诊断及管理中的应用。它为医疗服务提供者提供了关于患者准备、成像程序和结果解读的详细建议。该指南改编自国际标准并根据当地临床实践进行调整，强调了在包括脊柱感染、糖尿病足、骨髓炎、血管炎和心脏炎症等各种情况下该技术的安全性、质量控制和有效使用。其目的是帮助核医学专业人员做出准确诊断并改善患者预后，同时允许根据个体患者需求、技术进步和不断发展的医学知识进行灵活调整。本文档是提高氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描在评估感染性和炎症性疾病方面的质量和安全性的综合资源。
韩国核医学协会（KSNM）成立于1961年，旨在促进韩国核医学的临床和技术进步，其成员包括核医学医师及相关科学家。KSNM定期制定和修订核医学检查的程序指南，以推动该领域发展并提高患者护理质量。这些指南旨在支持医疗专业人员为患者提供适当的医疗服务。然而，它们并非进行检查的一成不变的规则或强制性要求。因此，KSNM声明这些指南不应在对医疗专业人员的医疗决策提出质疑的法律诉讼中使用。关于特定程序或适当措施的最终判断应由核医学医师根据每个病例的独特情况做出。偏离这些指南并不意味着医疗行为不达标。相反，可以根据患者病情、可用资源以及知识或技术的进步做出与指南不同的合理判断。由于患者的多样性和复杂性，预测最合适的诊断和准确的治疗反应往往具有挑战性。因此，遵循这些指南并不总能保证做出准确诊断或取得成功结果。本指南的目的是帮助医疗服务提供者在对感染性/炎症性疾病进行18F-氟代脱氧葡萄糖（18F-FDG）正电子发射断层扫描（PET）/计算机断层扫描（CT）检查时，基于当前医学知识、可用资源和患者需求做出合理决策并进行有效且安全的检查。
